Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $42.48 +5.86%
EPS Growth %: -35.0%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -35.0%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q1 EPS of ($0.81), $0.08 worse than the analyst estimate of ($0.73).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA grants accelerated approval to Vera Therapeutics' kidney drug
- Perplexity to use Nvidia's new CPUs for AI agent tasks
- Canada to invest up to C$400M in Teck Resources to boost critical metals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
